Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial. — ME/CFS Atlas
E1 ReplicatedPreliminaryPEM not requiredRCTPeer-reviewedReviewed
Standard · 3 min
Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.
Castro-Marrero, Jesus, Sáez-Francàs, Naia, Segundo, María Jose et al. · Clinical nutrition (Edinburgh, Scotland) · 2016 · DOI
Quick Summary
This study tested whether two supplements called CoQ10 and NADH could help people with ME/CFS feel less fatigued and improve their exercise capacity. Eighty patients took either the supplements or placebo for 8 weeks. The results showed modest improvements: the supplement group had lower maximum heart rates during exercise testing and reported less fatigue, but pain and sleep didn't improve.
Why It Matters
ME/CFS lacks approved pharmacological treatments, making exploration of potentially safe supplements valuable for patients seeking symptom relief. A reduction in maximum heart rate during standardized exercise testing could reflect improved cardiac efficiency or exercise tolerance, which are central concerns for ME/CFS patients. However, the mixed results underscore the need for further research before these supplements can be recommended as standard therapy.
Observed Findings
Maximum heart rate during cycle ergometry significantly decreased in the supplement group at week 8 versus baseline (P=0.022)
Fatigue perception showed a significant decrease in the active group across all follow-up visits compared to placebo (P=0.03)
Pain measures did not improve in the CoQ10 plus NADH group
Sleep quality did not improve in the active treatment group
The supplement combination was well-tolerated with no safety concerns reported
Inferred Conclusions
CoQ10 plus NADH supplementation is safe and may reduce maximum heart rate during standardized exercise testing in CFS patients
The supplement combination may have a modest beneficial effect on fatigue perception over 8 weeks
CoQ10 plus NADH does not appear to address all ME/CFS symptom domains, particularly pain and sleep
Larger and longer controlled trials are needed to confirm efficacy and establish clinical utility
Remaining Questions
Does the reduction in maximum heart rate translate to meaningful functional improvement or reduced post-exertional malaise?
What This Study Does Not Prove
This small 8-week trial does not establish that CoQ10 plus NADH is clinically effective or superior to placebo for most ME/CFS symptoms, as pain and sleep showed no benefit and fatigue improvement was modest. The study cannot determine the mechanism of action or whether benefits persist beyond 8 weeks. Statistical significance does not equal clinical meaningfulness, particularly given the lack of impact on multiple secondary outcomes.
Tags
Symptom:Unrefreshing SleepPainFatigue
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.